These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines. Osada H, Tatematsu Y, Sugito N, Horio Y, Takahashi T. Mol Carcinog; 2005 Dec 10; 44(4):233-41. PubMed ID: 16163707 [Abstract] [Full Text] [Related]
9. HDACs, histone deacetylation and gene transcription: from molecular biology to cancer therapeutics. Gallinari P, Di Marco S, Jones P, Pallaoro M, Steinkühler C. Cell Res; 2007 Mar 10; 17(3):195-211. PubMed ID: 17325692 [Abstract] [Full Text] [Related]
10. Cardiac histones are substrates of histone deacetylase activity in hemorrhagic shock and resuscitation. Lin T, Alam HB, Chen H, Britten-Webb J, Rhee P, Kirkpatrick J, Koustova E. Surgery; 2006 Mar 10; 139(3):365-76. PubMed ID: 16546502 [Abstract] [Full Text] [Related]
11. Epigenetic therapy in cancer: molecular background and clinical development of histone deacetylase and DNA methyltransferase inhibitors. Schneider-Stock R, Ocker M. IDrugs; 2007 Aug 10; 10(8):557-61. PubMed ID: 17665331 [Abstract] [Full Text] [Related]
12. Curcumin-induced histone hypoacetylation: the role of reactive oxygen species. Kang J, Chen J, Shi Y, Jia J, Zhang Y. Biochem Pharmacol; 2005 Apr 15; 69(8):1205-13. PubMed ID: 15794941 [Abstract] [Full Text] [Related]
13. Protein deacetylases: enzymes with functional diversity as novel therapeutic targets. Yoshida M, Shimazu T, Matsuyama A. Prog Cell Cycle Res; 2003 Apr 15; 5():269-78. PubMed ID: 14593721 [Abstract] [Full Text] [Related]
14. Transcription regulation by histone deacetylases. Wang S, Yan-Neale Y, Zeremski M, Cohen D. Novartis Found Symp; 2004 Apr 15; 259():238-45; discussion 245-8, 285-8. PubMed ID: 15171258 [Abstract] [Full Text] [Related]
15. Inhibition of MMTV transcription by HDAC inhibitors occurs independent of changes in chromatin remodeling and increased histone acetylation. Mulholland NM, Soeth E, Smith CL. Oncogene; 2003 Jul 31; 22(31):4807-18. PubMed ID: 12894222 [Abstract] [Full Text] [Related]
16. [Assay for inhibitory activity of histone deacetylase]. Yoshida M. Gan To Kagaku Ryoho; 2004 Apr 31; 31(4):507-11. PubMed ID: 15114691 [Abstract] [Full Text] [Related]
17. Histone deacetylase inhibition attenuates transcriptional activity of mineralocorticoid receptor through its acetylation and prevents development of hypertension. Lee HA, Lee DY, Cho HM, Kim SY, Iwasaki Y, Kim IK. Circ Res; 2013 Mar 29; 112(7):1004-12. PubMed ID: 23421989 [Abstract] [Full Text] [Related]
19. Statins increase p21 through inhibition of histone deacetylase activity and release of promoter-associated HDAC1/2. Lin YC, Lin JH, Chou CW, Chang YF, Yeh SH, Chen CC. Cancer Res; 2008 Apr 01; 68(7):2375-83. PubMed ID: 18381445 [Abstract] [Full Text] [Related]